TY - BOOK AU - National Academies of Sciences, Engineering, and Medicine A2 - Eve Higginbotham A2 - Maria Lund Dahlberg TI - The Impact of COVID-19 on the Careers of Women in Academic Sciences, Engineering, and Medicine SN - DO - 10.17226/26061 PY - 2021 UR - https://nap.nationalacademies.org/catalog/26061/the-impact-of-covid-19-on-the-careers-of-women-in-academic-sciences-engineering-and-medicine PB - The National Academies Press CY - Washington, DC LA - English KW - Policy for Science and Technology AB - The spring of 2020 marked a change in how almost everyone conducted their personal and professional lives, both within science, technology, engineering, mathematics, and medicine (STEMM) and beyond. The COVID-19 pandemic disrupted global scientific conferences and individual laboratories and required people to find space in their homes from which to work. It blurred the boundaries between work and non-work, infusing ambiguity into everyday activities. While adaptations that allowed people to connect became more common, the evidence available at the end of 2020 suggests that the disruptions caused by the COVID-19 pandemic endangered the engagement, experience, and retention of women in academic STEMM, and may roll back some of the achievement gains made by women in the academy to date. The Impact of COVID-19 on the Careers of Women in Academic Sciences, Engineering, and Medicine identifies, names, and documents how the COVID-19 pandemic disrupted the careers of women in academic STEMM during the initial 9-month period since March 2020 and considers how these disruptions - both positive and negative - might shape future progress for women. This publication builds on the 2020 report Promising Practices for Addressing the Underrepresentation of Women in Science, Engineering, and Medicine to develop a comprehensive understanding of the nuanced ways these disruptions have manifested. The Impact of COVID-19 on the Careers of Women in Academic Sciences, Engineering, and Medicine will inform the academic community as it emerges from the pandemic to mitigate any long-term negative consequences for the continued advancement of women in the academic STEMM workforce and build on the adaptations and opportunities that have emerged. ER - TY - BOOK AU - National Academies of Sciences, Engineering, and Medicine A2 - Paula Whitacre TI - The Food and Drug Administration's Emergency Use Authorization: Lessons Learned from the Past to Guide the Future: Proceedings of a Workshop–in Brief DO - 10.17226/26441 PY - 2021 UR - https://nap.nationalacademies.org/catalog/26441/the-food-and-drug-administrations-emergency-use-authorization-lessons-learned-from-the-past-to-guide-the-future PB - The National Academies Press CY - Washington, DC LA - English KW - Policy for Science and Technology AB - The U.S. Food and Drug Administration (FDA) has responsibility for protecting public health by ensuring the safety, efficacy, and security of drugs, biological products, and medical devices. In certain declared emergencies, FDA has the option to authorize use of a new product or a new use of an approved product - an authority known as Emergency Use Authorization (EUA)- if it has reason to believe that the product may be effective and that its known benefits outweigh its known risks. By contrast, in non-emergency situations, applicants must demonstrate a product's safety and effectiveness through a lengthier, more extensive process. On October 5-6, 2021, the Committee on Science, Technology, and Law of the National Academies of Sciences, Engineering, and Medicine convened a virtual workshop on the EUA process. At the workshop, presenters and participants examined FDA's recent and historic use of EUAs, discussed lessons learned during the COVID-19 pandemic, and considered how those lessons might inform future efforts. The workshop also highlighted emergency mechanisms used by other health regulators and considered how U.S. and global regulatory partners can strengthen cooperation in responding to global health emergencies. This publication summarizes the presentation and discussion of the workshop. ER - TY - BOOK AU - National Academies of Sciences, Engineering, and Medicine A2 - Paula Tarnapol Whitacre A2 - Marie Harton TI - Long-Term Impacts of COVID-19 on the Future Academic Careers of Women in STEM: Proceedings of a Workshop—in Brief DO - 10.17226/26687 PY - 2022 UR - https://nap.nationalacademies.org/catalog/26687/long-term-impacts-of-covid-19-on-the-future-academic-careers-of-women-in-stem PB - The National Academies Press CY - Washington, DC LA - English KW - Policy for Science and Technology AB - On March 23-24, 2022, the National Academies of Sciences, Engineering, and Medicine held a virtual workshop to explore the long-term impact of COVID-19 on the future careers of women in STEM. Workshop participants represented multiple sectors (i.e., higher education, government, and non-profit) as well as various career paths and stages (e.g., assistant, associate, and full professors; graduate students; program officers; directors; and policy advisors). The two-day workshop convened experts and leaders to outline a national research agenda that ensures academic institutions and federal agencies are able to monitor and mitigate the long-term negative impacts of the pandemic on the career trajectories, job stability, and leadership roles of women - especially women of color — in STEM. This publication highlights the presentation and discussion of the workshop. ER -